Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1702123 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.15Day −4.17%Mkt cap $115M1Y −21.2%Off 52W high −32.7%Vol (1Y) 66.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,244 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.2% of sh out |
| Days to cover2.7d |
| 13F net flow (QoQ)+15.12% |
| Top-10 13F concentration95.9% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-CAD 33.8M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CAD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+20.5% |
| 1Y−21.2% |
| 3Y+6.5% |
| Since incept. (ann.)−13.7% |
Total return through 2026-07-29 · series begins 2021-08-10. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)66.2% |
| Ann. volatility (3Y)78.9% |
| Sharpe (1Y)−0.11 |
| Sharpe (3Y)0.41 |
| Max drawdown (1Y)−39.5% |
| Max drawdown (3Y)−72.7% |
| Beta (3Y vs SPY)0.96 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MMCAP International Inc. SPC | 15.4M | $21M | 15.31% | +7247.4% |
| Tejara Capital Ltd | 5.1M | $7M | 5.12% | +0.0% |
| Ikarian Capital, LLC | 2.7M | $4M | 2.72% | new |
| CITADEL ADVISORS LLC | 819,904 | $1M | 0.82% | new |
| BOOTHBAY FUND MANAGEMENT, LLC | 794,881 | $1M | 0.79% | new |
| TWO SIGMA INVESTMENTS, LP | 534,211 | $721,185 | 0.53% | +31.3% |
| INTEGRITY ALLIANCE, LLC. | 465,025 | $629,830 | 0.46% | +6.9% |
| GOLDMAN SACHS GROUP INC | 332,400 | $448,740 | 0.33% | +1.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for CRDL.
